Literature DB >> 30520349

Safety of Sports for Young Patients With Implantable Cardioverter-Defibrillators: Long-Term Results of the Multinational ICD Sports Registry.

Elizabeth Vickers Saarel1, Ian Law2, Charles I Berul3, Michael J Ackerman4, Ronald J Kanter5, Shubhayan Sanatani6, Mitchell I Cohen7, Stuart Berger8, Peter S Fischbach9, David A Burton10, James Dziura11, Cynthia Brandt11, Laura Simone11, Fangyong Li1,11, Brian Olshansky12, David S Cannom13, Rachel J Lampert11.   

Abstract

BACKGROUND: Despite safety concerns, many young patients with implantable cardioverter-defibrillators (ICDs) participate in sports. We undertook a prospective, multinational registry to determine the incidence of serious adverse events because of sports participation. The primary end points were death or resuscitated arrest during sports or injury during sports because of arrhythmia or shock. Secondary end points included system malfunction and incidence of ventricular arrhythmias requiring multiple shocks for termination.
METHODS: Athletes with ICDs aged ≤21 years were included in this post hoc subanalysis of the ICD Sports Registry. Data on sports and clinical outcomes were obtained by phone interview and medical records review. ICD shocks and clinical details of lead malfunction were classified by 2 electrophysiologists.
RESULTS: A total of 129 young athletes participating in competitive (n=117) or dangerous (n=12) sports were enrolled. The mean age was 16 years (range, 10-21; 40% female; 92% white). The most common diagnoses were long QT syndrome (n=49), hypertrophic cardiomyopathy (n=30), and congenital heart disease (n=16). The most common sports were basketball and soccer, including 79 varsity/junior varsity high school and college athletes. During a median follow-up of 42 months, 35 athletes (27%) received 38 shocks. There were no occurrences of death, arrest, or injury related to arrhythmia, during sports. There was 1 ventricular tachycardia/ventricular fibrillation storm during competition. Freedom from lead malfunction was 92.3% at 5 years and 79.6% at 10 years.
CONCLUSIONS: Although shocks related to competition/practice are not uncommon, there were no serious adverse sequelae. Lead malfunction rates were similar to previously reported in unselected pediatric ICD populations. CLINICAL TRIAL REGISTRATION: URL: https://www.clinicaltrials.gov . Unique identifier: NCT00637754.

Entities:  

Keywords:  arrhythmias, cardiac; death, sudden, cardiac; defibrillators, implantable; shock; sports

Mesh:

Year:  2018        PMID: 30520349     DOI: 10.1161/CIRCEP.118.006305

Source DB:  PubMed          Journal:  Circ Arrhythm Electrophysiol        ISSN: 1941-3084


  7 in total

Review 1.  Role of Exercise as a Modulating Factor in Arrhythmogenic Cardiomyopathy.

Authors:  Alessandro Zorzi; Alberto Cipriani; Riccardo Bariani; Kalliopi Pilichou; Domenico Corrado; Barbara Bauce
Journal:  Curr Cardiol Rep       Date:  2021-05-07       Impact factor: 2.931

Review 2.  Sport Participation in Patients with Implantable Cardioverter-Defibrillators.

Authors:  Rachel Lampert
Journal:  Curr Treat Options Cardiovasc Med       Date:  2019-11-14

Review 3.  Sex-Specific Impacts of Exercise on Cardiovascular Remodeling.

Authors:  Rifat A Islam; Siri Sham S Khalsa; Arpita K Vyas; Roshanak Rahimian
Journal:  J Clin Med       Date:  2021-08-26       Impact factor: 4.964

4.  Video game ventricular tachycardia: The "Fortnite" phenomenon.

Authors:  Dustin Nash; Hae-Rhi Lee; Christopher Janson; Chalese Richardson-Olivier; Maully J Shah
Journal:  HeartRhythm Case Rep       Date:  2020-05-05

Review 5.  Smart Wearables for Cardiac Monitoring-Real-World Use beyond Atrial Fibrillation.

Authors:  David Duncker; Wern Yew Ding; Susan Etheridge; Peter A Noseworthy; Christian Veltmann; Xiaoxi Yao; T Jared Bunch; Dhiraj Gupta
Journal:  Sensors (Basel)       Date:  2021-04-05       Impact factor: 3.576

6.  Health-related quality of life and physical activity in children with inherited cardiac arrhythmia or inherited cardiomyopathy: the prospective multicentre controlled QUALIMYORYTHM study rationale, design and methods.

Authors:  Pascal Amedro; Oscar Werner; Hamouda Abassi; Aymeric Boisson; Luc Souilla; Sophie Guillaumont; Johanna Calderon; Anne Requirand; Marie Vincenti; Victor Pommier; Stefan Matecki; Gregoire De La Villeon; Kathleen Lavastre; Alain Lacampagne; Marie-Christine Picot; Constance Beyler; Christophe Delclaux; Yves Dulac; Aitor Guitarte; Philippe Charron; Isabelle Denjoy-Urbain; Vincent Probst; Alban-Elouen Baruteau; Philippe Chevalier; Sylvie Di Filippo; Jean-Benoit Thambo; Damien Bonnet; Jean-Luc Pasquie
Journal:  Health Qual Life Outcomes       Date:  2021-07-28       Impact factor: 3.186

7.  2021 PACES expert consensus statement on the indications and management of cardiovascular implantable electronic devices in pediatric patients.

Authors:  Maully J Shah; Michael J Silka; Jennifer N Avari Silva; Seshadri Balaji; Cheyenne M Beach; Monica N Benjamin; Charles I Berul; Bryan Cannon; Frank Cecchin; Mitchell I Cohen; Aarti S Dalal; Brynn E Dechert; Anne Foster; Roman Gebauer; M Cecilia Gonzalez Corcia; Prince J Kannankeril; Peter P Karpawich; Jeffery J Kim; Mani Ram Krishna; Peter Kubuš; Martin J LaPage; Douglas Y Mah; Lindsey Malloy-Walton; Aya Miyazaki; Kara S Motonaga; Mary C Niu; Melissa Olen; Thomas Paul; Eric Rosenthal; Elizabeth V Saarel; Massimo Stefano Silvetti; Elizabeth A Stephenson; Reina B Tan; John Triedman; Nicholas H Von Bergen; Philip L Wackel
Journal:  Indian Pacing Electrophysiol J       Date:  2021-07-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.